E
Elena Kum
Researcher at McMaster University
Publications - 22
Citations - 929
Elena Kum is an academic researcher from McMaster University. The author has contributed to research in topics: Medicine & Internal medicine. The author has an hindex of 4, co-authored 10 publications receiving 387 citations.
Papers
More filters
Journal ArticleDOI
Drug treatments for covid-19: living systematic review and network meta-analysis.
Reed A C Siemieniuk,Jessica J Bartoszko,Long Ge,Dena Zeraatkar,Ariel Izcovich,Elena Kum,Hector Pardo-Hernandez,Anila Qasim,Juan Pablo Diaz Martinez,Bram Rochwerg,Francois Lamontagne,Mi Ah Han,Qin Liu,Arnav Agarwal,Arnav Agarwal,Thomas Agoritsas,Derek K. Chu,Rachel Couban,Ellen Cusano,Andrea Darzi,Tahira Devji,Bo Fang,Carmen Fang,Signe Flottorp,Signe Flottorp,Farid Foroutan,Farid Foroutan,Maryam Ghadimi,Diane Heels-Ansdell,Kimia Honarmand,Liangying Hou,Xiaorong Hou,Quazi Ibrahim,Assem M. Khamis,Bonnie Lam,Mark Loeb,Maura Marcucci,Shelley McLeod,Sharhzad Motaghi,Srinivas Murthy,Reem A. Mustafa,Reem A. Mustafa,John Neary,Gabriel Rada,Irbaz Bin Riaz,Behnam Sadeghirad,Nigar Sekercioglu,Lulu Sheng,Ashwini Sreekanta,Charlotte Switzer,Britta Tendal,Lehana Thabane,George Tomlinson,Tari Turner,Per Olav Vandvik,Robin W.M. Vernooij,Andrés Viteri-García,Ying Wang,Liang Yao,Zhikang Ye,Gordon H Guyatt,Romina Brignardello-Petersen +61 more
TL;DR: Glucocorticoids probably reduce mortality and mechanical ventilation in patients with covid-19 compared with standard care and the effectiveness of most interventions is uncertain because most of the randomised controlled trials so far have been small and have important study limitations.
Journal ArticleDOI
Medical cannabis or cannabinoids for chronic non-cancer and cancer related pain: a systematic review and meta-analysis of randomised clinical trials.
Li Wang,Patrick Jiho Hong,Curtis May,Yasir Rehman,Yvgeniy Oparin,Chris J. Hong,Brian Y. Hong,Mahmood AminiLari,Lucas Gallo,Alka Kaushal,Samantha Craigie,Rachel Couban,Elena Kum,Harsha Shanthanna,Ira M Price,Suneel Upadhye,Mark A. Ware,Fiona Campbell,Rachelle Buchbinder,Thomas Agoritsas,Jason W. Busse +20 more
TL;DR: In this article, the benefits and harms of medical cannabis and cannabinoids for chronic pain were evaluated in 32 randomized clinical trials with 5,174 patients with chronic non-cancer pain and cancer related pain at ≥ 1.5 months.
Journal ArticleDOI
Prophylaxis against covid-19: living systematic review and network meta-analysis.
Jessica J Bartoszko,Reed A C Siemieniuk,Elena Kum,Anila Qasim,Dena Zeraatkar,Long Ge,Mi Ah Han,Behnam Sadeghirad,Arnav Agarwal,Arnav Agarwal,Thomas Agoritsas,Derek K. Chu,Rachel Couban,Andrea Darzi,Tahira Devji,Maryam Ghadimi,Kimia Honarmand,Ariel Izcovich,Assem M. Khamis,Francois Lamontagne,Mark Loeb,Maura Marcucci,Shelley McLeod,Sharhzad Motaghi,Srinivas Murthy,Reem A. Mustafa,John Neary,Hector Pardo-Hernandez,Gabriel Rada,Bram Rochwerg,Charlotte Switzer,Britta Tendal,Lehana Thabane,Per Olav Vandvik,Robin W.M. Vernooij,Andrés Viteri-García,Ying Wang,Liang Yao,Zhikang Ye,Gordon H Guyatt,Romina Brignardello-Petersen +40 more
TL;DR: In this paper, the authors compared the effects of drug prophylaxis on SARS-CoV-2 infection and covid-19 using living systematic review and network meta-analysis.
Journal ArticleDOI
A living WHO guideline on drugs to prevent covid-19.
Francois Lamontagne,Thomas Agoritsas,Reed A C Siemieniuk,Bram Rochwerg,Jessica J Bartoszko,Lisa Askie,Helen Macdonald,Wagdy Amin,Frédérique Jacquerioz Bausch,Erlina Burhan,Maurizio Cecconi,Duncan Chanda,Vu Quoc Dat,Bin Du,Heike Geduld,Patrick Gee,Harley Nerina,Madiha Hashimi,Beverley J. Hunt,Sushil K. Kabra,Seema Kanda,Leticia Kawano-Dourado,Yae Jean Kim,Niranjan Kissoon,Arthur Kwizera,Yee Sin Leo,Imelda Mahaka,Hela Manai,Greta Mino,Emmanuel Nsutebu,Natalia Pshenichnaya,Nida Qadir,Shalini Sri Ranganathan,Saniya Sabzwari,Rohit Sarin,Mike Sharland,Yinzhong Shen,João Paulo Souza,Miriam Stegemann,Sebastian Ugarte,Sridhar Venkatapuram,Dubula Vuyiseka,Jacobus Preller,Romina Brignardello-Petersen,Elena Kum,Anila Qasim,Dena Zeraatkar,Andrew Owen,Gordon H. Guyatt,Lyubov Lytvyn,Janet V. Diaz,Per Olav Vandvik,Michael Jacobs +52 more
TL;DR: The first version of this living guideline focuses on the evidence for hydroxychloroquine as discussed by the authors, while subsequent updates will cover other drugs being investigated for their role in the prevention of covid-19.
Journal ArticleDOI
Antibody and cellular therapies for treatment of covid-19: a living systematic review and network meta-analysis.
Reed A C Siemieniuk,Jessica J Bartoszko,Juan Pablo Diaz Martinez,Elena Kum,Anila Qasim,Dena Zeraatkar,Ariel Izcovich,Sophia O Mangala,Long Ge,Mi Ah Han,Thomas Agoritsas,Donald M. Arnold,Camila Ávila,Derek K. Chu,Rachel Couban,Ellen Cusano,Andrea Darzi,Tahira Devji,Farid Foroutan,Maryam Ghadimi,Assem M. Khamis,Francois Lamontagne,Mark Loeb,Anna Miroshnychenko,Sharhzad Motaghi,Srinivas Murthy,Reem A. Mustafa,Reem A. Mustafa,Gabriel Rada,Bram Rochwerg,Charlotte Switzer,Per Olav Vandvik,Robin W.M. Vernooij,Ying Wang,Liang Yao,Gordon H. Guyatt,Romina Brignardello-Petersen +36 more
TL;DR: In this paper, the authors evaluated the efficacy and safety of antiviral antibody therapies and blood products for the treatment of novel coronavirus disease 2019 (covid-19), with pairwise meta-analysis for outcomes with insufficient data.